Seasonal/Pandemic Influenza Stocks List

Recent Signals

Date Stock Signal Type
2021-03-05 INO Hammer Candlestick Bullish
2021-03-05 INO Doji - Bullish? Reversal
2021-03-05 INO Lizard Bullish Bullish Day Trade Setup
2021-03-05 INO Lower Bollinger Band Walk Weakness
2021-03-05 VBIV Hammer Candlestick Bullish
2021-03-05 VBIV Doji - Bullish? Reversal
2021-03-05 VBIV Lizard Bullish Bullish Day Trade Setup
2021-03-05 VBIV Lower Bollinger Band Walk Weakness

Recent News for Seasonal/Pandemic Influenza Stocks

Date Stock Title
Mar 4 INO INOVIO to Present at Upcoming Investor Conferences in March
Mar 3 INO Geneos Therapeutics Secures $12 Million in Series A1 Financing to Advance Personalized Cancer Immunotherapy Programs
Mar 2 VBIV VBI Vaccines Stock Could Blast Higher by 170%, Says Analyst
Mar 2 VBIV VBI Vaccines EPS misses by $0.15, misses on revenue
Mar 2 INO Why Inovio Stock Is Tanking Today
Mar 2 VBIV VBI Vaccines, Inc. (VBIV) Reports Q4 Loss, Lags Revenue Estimates
Mar 2 INO The Daily Biotech Pulse: Roxadustat Delay For FibroGen, AstraZeneca, Decision Day For KemPharm, NanoViricides Jumps On COVID-19 Drug Data
Mar 2 VBIV VBI Vaccines Reports Fourth Quarter and Full Year Financial Results for 2020, Provides Corporate Update and Outlook for 2021
Mar 2 INO Why Inovio's Positive Q4 Update Didn't Impress Investors
Mar 2 INO Inovio Pharmaceuticals (INO) Q4 2020 Earnings Call Transcript
Mar 2 INO Inovio Pharmaceuticals' (INO) CEO Joseph Kim on Q4 2020 Results - Earnings Call Transcript
Mar 1 INO Inovio shares slip afterhours despite positive phase 3 results for VGX-3100
Mar 1 INO Inovio Reports Q4 Earnings Beat, Mixed REVEAL 1 Data And Coronavirus Vaccine Update
Mar 1 INO Recap: Inovio Pharmaceuticals Q4 Earnings
Mar 1 INO UPDATE 1-Inovio completes enrolment in mid-stage U.S. study of COVID-19 vaccine
Mar 1 INO Inovio Pharmaceuticals EPS beats by $0.08, beats on revenue
Mar 1 INO INOVIO Reports Fourth Quarter 2020 and Year-End Financial Results
Mar 1 INO INOVIO Announces Positive Results from REVEAL 1, a Phase 3 Pivotal Trial Evaluating VGX-3100, its DNA-based HPV Immunotherapy for the Treatment of High-grade Precancerous Cervical Dysplasia Caused by HPV-16 and/or HPV-18
Mar 1 INO What You Need To Know In Options This Week: Gamestop, Zoom, Nio, Snowflake, Costco And More
Mar 1 INO Inovio Tops Estimates; Reports Positive Trial Results
Related Industries: Biotechnology